• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS / RESPIRONICS, INC. SYSTEM ONE; VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS / RESPIRONICS, INC. SYSTEM ONE; VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problems Cancer (3262); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/10/2020
Event Type  Injury  
Event Description
I began usage of the philips respironics medical device system one from 2012 to 2017.I was prescribed the medical device by yale sleep medicine by (b)(6), md.Usage was 4 hrs per day.During this duration, i experienced new and worsening medical conditions which could be presumptive conditions to pfas exposure.Glycemic dysfunction hyperglycemia insulin dysregulation diabetes type 2 hyperlipoidemia - worsening cholesterol during this time duration.Increased risk of testicular cancer.Testicular cancer, reproductive cancer recurrent internal, diseased para-aortic lymph node, yolk sac sarcoma - 2020.These conditions are well documented in medical records from 2012- 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYSTEM ONE
Type of Device
VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING
Manufacturer (Section D)
PHILIPS / RESPIRONICS, INC.
MDR Report Key17079460
MDR Text Key316775812
Report NumberMW5118220
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/06/2023
Patient Sequence Number1
Treatment
ASPIRIN ; D3; FARXIGA; FENOFILBRATE ; FISH OIL ; HUMALOG; LANTUS; LISINOPRIL ; MULTI-VITAMIN; ROSUVASTATIN ; SODIUM BICARBONATE; TUMERIC
Patient Outcome(s) Other; Hospitalization; Life Threatening; Disability;
Patient Age60 YR
Patient SexMale
Patient Weight97 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-